Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Financial Flexibility Index
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥98.10 Million (operating CF CN¥90.75 Million minus capex CN¥7.34 Million) represents 0% of total liabilities (CN¥2.46 Billion). Check Luoxin Pharmaceuticals Group Stock Co Lt (002793) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Luoxin Pharmaceuticals Group Stock Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Luoxin Pharmaceuticals Group Stock Co Ltd across 15 annual periods. See Luoxin Pharmaceuticals Group Stock Co Lt (002793) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Luoxin Pharmaceuticals Group Stock Co Ltd. For the full company profile including market capitalisation, see 002793 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥285.25 Million | CN¥253.07 Million | CN¥2.49 Billion | ▲ +875.6% |
| 2024 | -0.01x | CN¥-42.50 Million | CN¥-157.85 Million | CN¥2.88 Billion | ▼ -104.7% |
| 2023 | 0.31x | CN¥795.18 Million | CN¥552.79 Million | CN¥2.54 Billion | ▲ +301.6% |
| 2022 | -0.16x | CN¥-744.31 Million | CN¥-939.13 Million | CN¥4.80 Billion | ▼ -271.8% |
| 2021 | 0.09x | CN¥429.66 Million | CN¥120.63 Million | CN¥4.76 Billion | ▼ -7.3% |
| 2020 | 0.10x | CN¥328.36 Million | CN¥-32.40 Million | CN¥3.37 Billion | ▼ -51.1% |
| 2019 | 0.20x | CN¥696.91 Million | CN¥116.33 Million | CN¥3.50 Billion | ▼ -67.6% |
| 2018 | 0.61x | CN¥301.99 Million | CN¥114.12 Million | CN¥491.85 Million | ▼ -66.3% |
| 2017 | 1.82x | CN¥263.34 Million | CN¥102.27 Million | CN¥144.74 Million | ▲ +45.0% |
| 2016 | 1.25x | CN¥143.75 Million | CN¥72.74 Million | CN¥114.56 Million | ▲ +164.0% |
| 2015 | 0.48x | CN¥99.85 Million | CN¥58.12 Million | CN¥210.10 Million | ▼ -35.4% |
| 2014 | 0.74x | CN¥97.41 Million | CN¥41.83 Million | CN¥132.40 Million | ▼ -2.3% |
| 2013 | 0.75x | CN¥84.23 Million | CN¥64.75 Million | CN¥111.80 Million | ▲ +10.0% |
| 2012 | 0.69x | CN¥114.28 Million | CN¥33.31 Million | CN¥166.77 Million | ▲ +17.8% |
| 2011 | 0.58x | CN¥69.84 Million | CN¥46.53 Million | CN¥120.07 Million | — |